29 January 2020 - CVS Health Corp said its pharmacy benefit management unit is launching a new program, under which employers and insurers will be able to offer diabetes drugs, including insulin, at no out-of-pocket costs to their members.

The company said the program would not raise costs for health insurers and employers, and eliminating out-of-pocket costs would ensure better adherence by diabetic patients to their drug regimens.

Read Reuters article